¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"effective half life"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® half-life ÇÑ±Û ¹Ý°¨±â
¼³¸í   
  ¾î¶² ¹°ÁúÀÌ ¿ÜºÎÀû ¿äÀÎ, ¶Ç´Â ³»ºÎÀû ¿äÀο¡ ÀÇÇØ¼­ ºÐÇØµÉ °æ¿ì¿¡ ±× ¹°ÁúÀÇ ¿ø·¡ÀÇ ¾ç¿¡¼­ ¹ÝÀÌ µÇ´Â µ¥ °É¸®´Â ½Ã°£.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • half and half nail
    ¹Ý°ú¹Ý¼Õ¹ßÅé
  • antibody half-life
    Ç×ü¹Ý°¨±â
  • biologic half-life
    »ý¹°ÇÐÀû¹Ý°¨±â
  • biological half life
    »ý¹°ÇÐÀû¹Ý°¨±â
  • half-life
    ¹Ý°¨±â
  • half bath
    ¹Ý½Å¸ñ¿å, ¹Ý½Å¿å
  • half elimination rate
    ¹Ý°¨·ü
  • half shell crown
    ¹Ý±Ý°ü
  • half survival time
    ¹Ý°¨»ýÁ¸½Ã°£
  • half-axial projection
    ¹ÝÃ༺Åõ»ç
  • half-normal saline
    1/2»ý¸®½Ä¿°¼ö
  • half-normal solution
    ¹Ý±ÔÁ¤¾×
  • half-value layer
    ¹Ý°¡Ãþ
  • average life expectancy
    Æò±Õ¿©¸í
  • advanced cardiac life support
    »ó±Þ½ÉÀå¼Ò»ý¼ú, Àü¹®½ÉÀå¼Ò»ý¼ú
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • half-life
    ¹Ý°¨±â
  • effective dose
    À¯È¿¿ë·®, À¯È¿¼±·®
  • effective demand
    À¯È¿¼ö¿ä
  • life style disease
    »ýȰ½À°üº´
  • life
    »ýȰ
  • effective blood volume
    À¯È¿Ç÷¾×·®
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • antibody half-life
    Ç×ü¹Ý°¨±â
  • biological half life
    »ý¹°ÇÐÀû¹Ý°¨±â
  • elimination half-life
    ¼Ò½Ç¹Ý°¨±â
  • half-life
    ¹Ý°¨±â
  • physical half life
    ¹°¸®Àû¹Ý°¨±â
  • half bath
    ¹Ý½Å¸ñ¿å
  • half shell crown
    ¹Ý±Ý°ü
  • half tone
    ¹ÝÀ½
  • half elimination rate
    ¹Ý°¨·ü
  • half survival time
    ¹Ý°¨»ýÁ¸½Ã°£
  • half waking somnambulism
    ¹Ý°¢¼º¸ùÀ¯º´
  • half-normal solution
    ¹Ý±ÔÁ¤¾×
  • half-value layer
    ¹Ý°¡Ãþ
  • abridged life table
    °£ÀÌ»ý¸íÇ¥
  • aerospace life support system
    ¿ìÁÖ»ý¸íÀ¯Áö°èÅë
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • antibody half-life
    Ç×ü¹Ý°¨±â(ù÷ô÷ÚâÊïÑ¢).
  • half-life
    ¹Ý°¨±â
  • physical half life
    ¹°¸®Àû ¹Ý°¨±â(ÚªìµîÜ ÚâÊõÑ¢).
  • physical half-life
    ¹°¸®Àû¹Ý°¨±â
  • half and half nail
    ¹Ý¹Ý Á¶°©
  • abridged life table
    °£ÀÌ»ý¸íÇ¥(˧ËöË×ËḬ̂).
  • advanced cardiac life support
    ÀÌÂ÷ (½ÉÆó)¼Ò»ý¼ú
  • advanced trauma life support
    »ó±Þ ¿Ü»ó¼Ò»ý¼ú
  • aerospace life support system
    (Ç×°ø)¿ìÁÖ¿ë »ý¸íÀ¯Áö½Ã½ºÅÛ.
  • phase of life problem
    ÀλýÁÖ±âÀÇ ¹®Á¦
  • quality of life
    »îÀÇ Áú
  • EAV=£¾effective alveolar ventilation
    À¯È¿ÆóÆ÷ȯ±â(·®).
  • ED 50=£¾effective dose 50%
    50% À¯È¿·®, Áß°£À¯È¿·®.
  • ED 50=£¾effective dose 50%
    50% À¯È¿·®.
  • ELBF=£¾effective liver blood flow
    À¯È¿¼º °£Ç÷·ù.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • effective half life
    À¯È¿¹Ý°¨±â.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • effective half-life
    À¯È¿¹Ý°¨±â
  • half and half nail
    ¹Ý¹Ý Á¶°©
  • antibody half-life
    Ç×ü¹Ý°¨±â(ù÷ô÷ÚâÊïÑ¢).
  • biological half life
    ½Å±¤ [¹ÙÀÌ,°£È£]»ý¹°ÇÐÀû ¹Ý°¨±â(¡­ÚâÊõÑ¢).
  • biological half life
    »ý¹°ÇÐÀû ¹Ý°¨±â(¡­ÚâÊõÑ¢)
  • biological half life
    [½ÅÀå,¹ÙÀÌ,°£È£]»ý¹°ÇÐÀû ¹Ý°¨±â(¡­ÚâÊõÑ¢).
  • elimination half-life
    ¼Ò½Ç¹Ý°¨±â.
  • half-life
    ¹Ý°¨±â
  • physical half life
    ¹°¸®Àû ¹Ý°¨±â(ÚªìµîÜ ÚâÊõÑ¢).
  • physical half-life
    ¹°¸®Àû¹Ý°¨±â
  • half Fourier imaging
    ¹Ý Fourier ¿µ»ó
  • half bath
    ¹Ý½Å¿å(Úâãóé±).
  • half elimination rate
    1/2Á¦°ÅÀ²(ð¶ËÛëÒ), ¹Ý°¨·ü(ÚâÊõ×Ë)
  • half elimination rate
    1/2Á¦°ÅÀ², ¹Ý°¨·ü.
  • half fat cheese
    ¹ÝÅ»ÁöÄ¡ÀÌÁî.
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • life cycle
    »ýȰ»ç
  • sylvatic life cycle
    ¹Ð¸²»ýȰȯ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • effective half-life
    À¯È¿ ¹Ý°¨±â(êóüùÚâÊõÑ¢)
  • biological half-life
    »ý¹°ÇÐÀû ¹Ý°¨±â(ßæÚªùÊîÜÚâÊõÑ¢)
  • half-life
    ¹Ý°¨±â(ÚâÊõÑ¢)
  • physical half-life
    ¹°¸®Àû ¹Ý°¨±â(Úª×âîÜÚâÊõÑ¢)
  • radioactive half-life
    ¹æ»ç¼º ¹Ý°¨±â(Û¯ÞÒàõÚâÊõÑ¢)
  • effective concentration
    À¯È¿ ³óµµ (êóüùÒØÓø)
  • effective lethal phase
    À¯È¿ Ä¡»ç±â(êóüùöÈÞÝÑ¢)
  • median effective dose
    Á¤Áß À¯È¿·®(ïáñéêóüùÕá)
  • life cycle
    "»ýȰ»ç(ßæüÀÞÈ),»ýȰÁÖ±â(ßæüÀñÎÑ¢)"
  • half-band width
    ¹Ý¶ì ³Êºñ
  • half-cell
    ¹Ý½Ç(Úâãø)
  • half-of-the-sites reactivity
    ¹Ý(Úâ)ÀÚ¸® ¹ÝÀÀ¼º (Úãëëàõ)
  • half-period
    ¹Ý±â°£(ÚâÑ¢Êà)
  • half-reaction
    ¹Ý¹ÝÀÀ(ÚâÚãëë)
  • half-reaction time
    ¹Ý¹ÝÀÀ ½Ã°£(ÚâÚãëëãÁÊà)
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • effective half life
    À¯È¿¹Ý°¨±â
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • half-life; half-time
    ¹Ý°¨±â
  • biological half life
    »ý¹°ÇÐÀû¹Ý°¨±â
  • elimination half-life
    ¼Ò½Ç¹Ý°¨±â
  • physical half-life
    ¹°¸®Àû ¹Ý°¨±â
  • effective TR
    À¯È¿¹Ýº¹½Ã°£
  • minimal effective dose
    ÃÖ¼ÒÀ¯È¿·®
  • half Fourier imaging
    ¹ÝFourier¿µ»ó
  • half lethal dose
    ¹ÝÄ¡»ç·®
  • life cycle
    »ýȰȯ, »ýȰ ÁÖ±â
  • life threatening
    »ý¸íÀ» À§ÇùÇÏ´Â
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
Te effective Half-Life
EHL effective half-life; electrohydraulic lipotripsy; endogenous hyperlipidemia; Environmental Health La...
Te effective half-life; tellurium; tetanic contraction; tetanus
Teff effective half-life
AERP antegrade effective refractory period; atrial effective refractory period
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
T(1/2) Terminal half-life
T 1/2 The biological half life
T 1/2 The elimination half life
T 1/2 The mean half-life
HVL 6-half-value layer
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • antibody half-life
    Ç×ü ¹Ý°¨±â
    Ç×ü ºÐÀÚ°¡ Çü¼ºµÈ ÈÄ Æò±Õ »ýÁ¸ÇÏ´Â ½Ã°£À» ÃøÁ¤ÇÏ´Â °ÍÀ¸·Î¼­, º¸Åë µ¿¹°Ã¼³»¿¡¼­ ÀÏÁ¤·®ÀÇ ¸é¿ª ±Û·ÎºÒ¸°ÀÇ 50%¸¦ Á¦°ÅÇÏ´Â µ¥ °É¸®´Â ½Ã°£À¸·Î Ç¥½ÃÇÑ´Ù. ÀÌ ¹Ý°¨±â´Â ¸é¿ª ±Û·ÎºÒ¸°ÀÇ Á¾·ù¿¡ µû¶ó ´Ù¸£´Ù.
  • elimination half-life
    ¼Ò½Ç ¹Ý°¨±â
  • half-life of immunoglobulin
    ¸é¿ª ±Û·ÎºÒ¸°ÀÇ ¹Ý°¨±â
  • half asleep
    °¡¸é, ¹Ý¼ö¸é
    ¹ÝÀº Àáµé°í ¹ÝÀº ÀáµéÁö ¾ÊÀº »óÅÂ.
  • half impaction of the tooth
    ¹Ý ¸Åº¹Ä¡
    Ä¡¾Æ°¡ ¿ÏÀüÈ÷ ¸ÍÃâµÇÁö ¾Ê°í ¹Ý¸¸ ¸ÍÃâµÇ°í ¹ÝÀº °ñ³»¿¡ ¸Åº¹µÇ¾î ÀÖ´Â Ä¡¾Æ.
  • half round tube
    ¹Ý¿ø °ü
  • half spherical cavity
    ¹Ý±¸Çü ¿Íµ¿
  • half the number
    ¹Ý¼ö
  • half vision
    Çü»ó ½Ã
  • half way house
    Áß°£ÂëÀÇ ÁÖ°Åó, Áß°£ Á¡
    Á¤½Å°ú ȯÀÚ, ¾à¹° Áßµ¶ÀÚ, ¾ËÄÝ Áßµ¶ÀÚ °°Àº ȯÀÚµé Áß ¿ÏÀü ÀÔ¿øÀº ÇÊ¿äÄ¡ ¾ÊÀ¸³ª ±×µéÀÌ °øµ¿ »çȸ¿¡ ´Ù½Ã Á¤ÂøµÇ±â±îÁö ÁߵÀÇ °£È£°¡ ÇÊ¿äÇÑ È¯ÀÚµéÀÇ °ÅÁÖó.
  • lower half headache
    ¾È¸é ÇϹݺΠµÎÅë, ÇϹݺΠµÎÅë
  • one : À¯±âÈ­Çп¡¼­ ÄÉÅæÀÌ ÀÖÀ½À» ³ªÅ¸³»´Â Á¢¹Ì¾î.

    one and one-half syndrome

    1°ú 1/2 ÁõÈıº
  • committed effective dose equivalent
    ¿¹Å¹ À¯È¿ ¼±·® ´ç·®
  • effective
    À¯È¿ÇÑ
    ÀǵµµÈ °á°ú¸¦ ÀÏÀ¸Å³ ¼ö ÀÖ´Â.
  • effective arterial volume
    À¯È¿ µ¿¸ÆÇ÷·®
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
effective half-life <radiobiology> Time required for a radioactive substance contained in a biological system (such as a person or an animal) to reduce its radioactivity by half, as a combination result of radioactive decay and biological elimination from the system.
(09 Oct 1997)
half and half nail Division of the nail by a transverse line into a proximal dull white part and a distal pink or brown part; seen in uraemia.
(05 Mar 2000)
biological half-life <biochemistry, biology> This is the time required for one-half of the total amount of a particular substance in a biological system to be consumed or broken down by biological processes when the rate of removal is approximately exponential.
Toxic chemicals with a long biological half-life (such as some pesticides) will tend to accumulate in the body and are, therefore, more likely to be harmful. A substance with a short biological half-life may still accumulate if a portion of it it becomes tightly bound to bone or other tissues, even if most of it is quickly cleared from the body.
(21 Mar 1998)
physical half-life The time required for half the atoms of a radionuclide to undergo disintegration.
(05 Mar 2000)
half-life 1. <pharmacology> The period over which the concentration of a specified chemical or drug takes to fall to half its original concentration in the specified fluid or blood.
2. <radiobiology> The time required to reduce the amount of a radionuclide to one-half the amount originally present. Physical or radioactive half-life refers to reduction of activity by radioactive decay, biological half-life refers to biological elimination from the body and effective half-life refers to the combined action of radioactive decay and biological elimination.
(16 Dec 1997)
drug half-life The amount of time it takes for one-half of an administered drug to be lost through biological processes (metabolism and elimination).
(27 Sep 1997)
elimination half-life <pharmacology> The time it takes for the body to eliminate or breakdown half of a dose of a pharmacologic agent.
(09 Oct 1997)
aperture, effective <microscopy> The diameter of the entrance pupil: it is the apparent diameter of the limiting aperture measured from the front.
(05 Aug 1998)
renal blood flow, effective The amount of blood flowing to the parts of the kidney that are involved with the production of constituents of urine. It is that portion of the total renal blood flow that perfuses functional renal tissue (e.g., the glomeruli). It should be differentiated from renal plasma flow, effective which is based on the amount of plasma rather than on total renal blood.
(12 Dec 1998)
median effective dose The dose that produces the desired effect; when followed by a subscript (generally "ED50"), it denotes the dose having such an effect on a certain percentage (e.g., 50%) of the test animals; ED50 is the median effective dose, in radiation protection, the sum of the equivalent doses in all tissues and organs of the body weighted for tissue effects of radiation. The unit of effective dose is the sievert (Sv), epilation dose, the minimum amount of radiation sufficient to produce hair loss, usually in 10 to 14 days.
(05 Mar 2000)
cost-effective A term describing a resource that is available within the time it is needed and is able to meet or reduce electrical power demand at an estimated incremental system cost no greater than that of the least-costly, similarly reliable and available alternative.
(05 Dec 1998)
effective Producing the intended result.
(18 Nov 1997)
effective collision radius <radiobiology> Effective size of a particle equal to the square root of (cross-section/pi). Determines the effective range of interaction of the particle.
(09 Oct 1997)
effective conjugate The internal conjugate measured from the nearest lumbar vertebra to the symphysis, in spondylolisthesis.
Synonym: false conjugate.
(05 Mar 2000)
effective dose The dose that produces the desired effect; when followed by a subscript (generally "ED50"), it denotes the dose having such an effect on a certain percentage (e.g., 50%) of the test animals; ED50 is the median effective dose, in radiation protection, the sum of the equivalent doses in all tissues and organs of the body weighted for tissue effects of radiation. The unit of effective dose is the sievert (Sv), epilation dose, the minimum amount of radiation sufficient to produce hair loss, usually in 10 to 14 days.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • half life
    ¹Ý°¨±â
  • half life
    (¹Ý»ç´É)¹Ý°¨±â
  • effective
    È¿°úÀûÀÎ
  • cost-effective
    ºñ¿ëÈ¿À²ÀûÀÎ
  • effective
    À¯È¿ÇÑ;È¿°úÀûÀÎ;ÀλóÀûÀÎ;»ç½Ç»óÀÇ;½ÇÁ¦ÀÇ;È¿·ÂÀÖ´Â;µ¿¿ø°¡´ÉÇÑ;º´·Â;´«¿¡ ¶ç´Â
  • effective aperture
    (±¤)(·»ÁîÀÇ) À¯È¿ ±¸°æ
  • effective demand
    (°æ)À¯È¿ ¼ö¿ä
  • effective exchange rate
    (±ÝÀ¶)½ÇÈ¿ ȯ½Ã¼¼(ȯÀ²)(±¹Á¦ÅëÈ­±â±ÝÀÌ ´çÇØ±¹°ú ´Ù¸¥ ÁÖ¿ä 20°³±¹ ÅëÈ­ÀÇ È¯½Ã¼¼¸¦ º¹ÇÕ½ÃÄÑ »êÃâÇÏ´Â Áö¼ö)
  • effective money (coin)
    °æÈ­
  • effective range
    (°ø)À¯È¿ »ç°Å¸®(»çÁ¤)
  • for one's life
    ÇÊ»çÀûÀ¸·Î
  • for the life of me
    ¾Æ¹«¸®Çصµ
  • life
    »ý¸í,ÀÏ»ý,Àλý,»ýȰ
  • life-giving
    »ý¸íÀ» ÁÖ´Â
  • life-size
    ½Ç¹° Å©±âÀÇ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á